# Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea

> **NCT06995287** · PHASE3 · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 222 (estimated)

## Conditions studied

- Primary Dysmenorrhea
- Chronic Pelvic Pain

## Interventions

- **DRUG:** Xeomin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06995287
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2028-06-09
- **Final completion:** 2028-09-09
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995287, "Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06995287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*